Binimetinib Des Ethanediol Impurity

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Binimetinib Des Ethanediol Impurity is a process-related impurity formed during the synthesis or degradation of Binimetinib, typically resulting from the loss (“des-”) of an ethanediol moiety from the parent structure. It is mainly studied in pharmaceutical analysis to monitor drug purity, stability, and quality control, especially for compounds targeting the MAPK/ERK signaling pathway

Binimetinib Des Ethanediol Impurity

Head Office Address

Our Office Addresses